000			02158 a2200601 4500
005			20250516040309.0
264		0	_c20110912
008			201109s 0 0 eng d
022			_a1479-5876
024	7		_a10.1186/1479-5876-9-71 _2doi
040			_aNLM _beng _cNLM
100	1		_aRao, Jia
245	0	0	_aCurcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. _h[electronic resource]
260			_bJournal of translational medicine _cMay 2011
300			_a71 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntigens, CD34 _xmetabolism
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCurcumin _xpharmacology
650	0	4	_aDaunorubicin _xpharmacology
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aFemale
650	0	4	_aG1 Phase _xdrug effects
650	0	4	_aGene Expression Regulation, Leukemic _xdrug effects
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xenzymology
650	0	4	_aMale
650	0	4	_aMembrane Potential, Mitochondrial _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aPoly(ADP-ribose) Polymerases _xmetabolism
650	0	4	_aProtein Processing, Post-Translational _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRNA, Small Interfering _xmetabolism
650	0	4	_aS Phase _xdrug effects
700	1		_aXu, Duo-Rong
700	1		_aZheng, Fei-Meng
700	1		_aLong, Zi-Jie
700	1		_aHuang, Sheng-Shan
700	1		_aWu, Xing
700	1		_aZhou, Wei-Hua
700	1		_aHuang, Ren-Wei
700	1		_aLiu, Quentin
773	0		_tJournal of translational medicine _gvol. 9 _gp. 71
856	4	0	_uhttps://doi.org/10.1186/1479-5876-9-71 _zAvailable from publisher's website
999			_c20857826 _d20857826